tiprankstipranks
Verici Dx Announces AGM and Annual Report
Company Announcements

Verici Dx Announces AGM and Annual Report

Verici Dx Plc (GB:VRCI) has released an update.

Don't Miss our Black Friday Offers:

Verici Dx Plc, a company specializing in advanced diagnostics for organ transplants, has announced the availability of its 2023 Annual Report and the Notice of its 2024 AGM on its website. Shareholders are informed that the AGM will take place on June 25, 2024, and that electronic proxy voting is available through a provided link, with a hard copy form obtainable upon request. The company emphasizes its focus on developing a kidney transplant platform driven by AI-assisted transcriptomic analysis for improved patient outcomes.

For further insights into GB:VRCI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskVerici Dx Foresees TutiviaTM Revenue Shift to FY25
TipRanks UK Auto-Generated NewsdeskVerici Dx Launches Groundbreaking Transplant Risk Assay
TipRanks UK Auto-Generated NewsdeskVerici Dx Plc Reports Revenue Growth and Strategic Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App